Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05959629 · ClinicalTrials.gov registry record · NA
Erbium, Chromium: Yttrium, Scandium, Gallium, Garnet (Er,Cr:YSGG) Laser in Root Canal Disinfection
A NA study, sponsored by University of Pennsylvania.
- Terminated
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT05959629: Clinical Trial NA study, sponsored by University of Pennsylvania.
NCT05959629 is a NA study that was terminated before completion, run by University of Pennsylvania. The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05959629, a NA study, was terminated before completion, sponsored by University of Pennsylvania.
- TERMINATED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a protocol for biofilms disinfection with a FDA cleared, clinically approved and commercially available Er,Cr:YSGG laser treatments. This protocol will be testing local single topical application of Lasers within the canal system in patients going through routine endodontic treatment, evaluate its potential as anti-biofilm treatment and compare it to other currently used antibacterial protocols.
Interventions
- DEVICE Waterlase Express™, BIOLASE®
- OTHER Sodium Hypochlorite
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2023-10-11 |
| Est. Completion | 2024-05-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05959629
The ClinicalTrials.gov registry entry for NCT05959629 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Waterlase Express™, BIOLASE® is the first listed.
NCT05959629 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05959629 about?
NCT05959629 is a clinical study titled "Erbium, Chromium: Yttrium, Scandium, Gallium, Garnet (Er,Cr:YSGG) Laser in Root Canal Disinfection". The purpose of this study is to develop a protocol for biofilms disinfection with a FDA cleared, clinically approved and commercially available Er,Cr:YSGG laser treatments. This protocol will be testing local single topical application of Lasers within the canal system in patients going through rout...
What is the current status of trial NCT05959629?
This trial is currently terminated. It is a NA study. The enrollment target is 56 participants. The study started on 2023-10-11. Estimated completion is 2024-05-02.
What interventions are being tested in trial NCT05959629?
The interventions under investigation include: Waterlase Express™, BIOLASE® (DEVICE), Sodium Hypochlorite (OTHER).
Who is sponsoring clinical trial NCT05959629?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.